Abstracts Archive - Page 1638 of 2425 - ACR Meeting Abstracts

Abstract Number: 2489 • 2015 ACR/ARHP Annual Meeting
Effects of Two Interventions on Rheumatologists Adherence to Optimal Care Recommendations in Rheumatoid Arthritis: A Combined before/after and Randomized Controlled Trial
Nienke Lesuis¹, Ronald van Vollenhoven², Marlies Hulscher³ and Alfons den Broeder¹, ¹Rheumatology, Sint Maartenskliniek, Nijmegen, Netherlands, ²ClinTRID, Department of Medicine, Karolinska Institute, Stockholm, Sweden, ³IQ Healthcare, Radboud University Medical Centre, Nijmegen, Netherlands
Background/Purpose: Current treatment guidelines for rheumatoid arthritis (RA) recommend using tight control strategies.1 Despite evidence for the benefits of this strategy, physician adherence is suboptimal.2,3…
Abstract Number: 2490 • 2015 ACR/ARHP Annual Meeting
Implementation of Disease Activity Measurement for Rheumatoid Arthritis Patients in an Academic Rheumatology Clinic
Alison Bays¹, Elizabeth R. Wahl², David I. Daikh³, Jinoos Yazdany⁴ and Gabriela Schmajuk⁵, ¹Rheumatology, University of Washington, Seattle, WA, ²Medicine/Rheumatology, San Francisco Veterans Affairs Medical Center, San Francisco, CA, ³Rheumatology, UCSF/VA Medical Center, San Francisco, CA, ⁴Rheumatology, UCSF, SF, CA, ⁵San Francisco VA Medical Center, University of California, San Francisco, San Francisco, CA
Background/Purpose: Current recommendations for optimal rheumatoid arthritis (RA) management include routine assessment of disease activity and adjustment of medication to achieve remission or low disease…
Abstract Number: 2491 • 2015 ACR/ARHP Annual Meeting
Documentation of Disease Activity Score As Part of a Treat to Target Strategy in Rheumatoid Arthritis
Sarah Homann¹ and Beth Scholz², ¹Rheumatology, University of Texas Health Sciences Center at Houston, Houston, TX, ²University of Texas Health Sciences Center at Houston, Houston, TX
Background/Purpose: Compared to routine care, the Treat to Target (TTT) strategy for rheumatoid arthritis (RA) has been validated to improve functional and radiographic outcomes via…
Abstract Number: 2492 • 2015 ACR/ARHP Annual Meeting
Implementation of the Clinical Disease Activity Index to Treat to Target Rheumatoid Arthritis in the Ambulatory Setting: A Plan Do Study Act Quality Analysis
Irene Lazarus¹, Salahuddin Kazi², Alok Dwivedi³, Christopher Dodoo⁴, Riya Joseph⁵, Mariela Hernandez⁶, Cam Duong⁷, Yasmin Sabet⁸ and Kanchan Pema⁹, ¹Internal Medicine, Texas Tech University Health Science Center, El Paso, TX, ²Internal Medicine/Rheumatology, UT Southwestern Medical Center, Dallas, TX, ³Biomedical Sciences Division of Biostatistics and Epidemiology, Texas Tech University Health Sciences Center, El Paso, TX, ⁴Texas Tech University Health Sciences Center, El Paso, TX, ⁵Internal Medicine, Methodist Dallas Medical Center, Dallas, TX, ⁶Paul Foster Medical School, Texas Tech University Health Sciences Center, El Paso, TX, ⁷Paul Foster School of Medicine, Texas Tech University Health Sciences Center, El Paso, TX, ⁸Internal Medicine, Texas Tech University Health Sciences Center, El Paso, TX, ⁹Internal Medicne/Rheumatology, Texas Tech University Health Science Center, El Paso, TX
Background/Purpose: Achieving tight control of RA with reliable methods to monitor and assess disease activity in a more objective way is imperative in clinical practice…
Abstract Number: 2493 • 2015 ACR/ARHP Annual Meeting
Improvement of Disease Activity and Quality of Care in a Cohort of Rheumatoid Arthritis Patients Treated with Conventional Dmard Therapy Under Treat to Target Recommendations and a Model of Patient-Centered Care
Pedro Ivan Santos-Moreno¹, Ginna Saavedra², Rosana Ramirez², Laura Villarreal², Ana Bolena Cardozo², Vanessa Giraldo², Paola Martinez², Adriana Sanchez², Merle Sanchez², Danny Gomez² and Juan Manuel Bello², ¹Rheumatology, Biomab, Center for Rheumatoid Arthritis., Bogota, Colombia, ²Rheumatology, Biomab, Center for Rheumatoid Arthritis, Bogota, Colombia, Bogota, Colombia
Background/Purpose: Treat to Target (T2T) strategy becomes from the need to develop therapeutic targets and tools to achieve defined outcomes in rheumatoid arthritis (RA). Moreover,…
Abstract Number: 2494 • 2015 ACR/ARHP Annual Meeting
An Electronic Safety Dashboard for Rheumatology Clinics
Mary Margaretten¹, Laura Trupin¹, Sarah Goglin² and Jinoos Yazdany¹, ¹University of California, San Francisco, San Francisco, CA, ²Rheumatology, University of California, San Francisco, San Francisco, CA
Background/Purpose: Patient safety problems are increasing in rheumatology given the growing use of high-risk immunosuppressive drugs. Electronic health record "dashboards" have been utilized in research…
Abstract Number: 2495 • 2015 ACR/ARHP Annual Meeting
Tele-Monitoring of Disease Activity in Rheumatoid Arthritis and Psoriatic Arthritis
Alexander Langer¹ and Hans-Eckhard Langer², ¹Department of Computer Science, RWTH Aachen University, Aachen, Germany, ²RHIO (Rheumatology, Immunology, and Osteology), Duesseldorf, Germany
Background/Purpose: There is evidence that tight control of rheumatoid arthritis improves outcome. In daily practice this aim is constricted by logistic limitations such as a…
Abstract Number: 2496 • 2015 ACR/ARHP Annual Meeting
Telerheumatology: A Technology Not Appropriate for All
Zsolt Kulcsar^1,2, Daniel Albert³, Ellyn Ercolano⁴ and John Mecchella⁵, ¹Rheumatology, Dartmouth Hitchcock Medical Center, Lebanon, NH, ²Rheumatology/Leadership Preventive Medicine Residency, Dartmouth Hitchcock Medical Center, lebanon, NH, ³Medicine/Rheumatology, Dartmouth-Hitchcock Med Ctr, Lebanon, NH, ⁴Telehealth, Dartmouth Hitchcock Center For Telehealth, Lebanon, NH, ⁵Rheumatology, Dartmouth-Hitchcock Medical Center, Lebanon, NH
Title: Telerheumatology: A Technology Not Appropriate For AllBackground/Purpose: Access to Rheumatology care in New Hampshire (NH) and Vermont (VT) is limited, as a large proportion…
Abstract Number: 2497 • 2015 ACR/ARHP Annual Meeting
Satisfaction with the Initial Evaluation for a Rheumatologic Complaint Using Telemedicine
Tracy Nguyen-Oghalai¹, Michael Lyon² and Kathy Hunter³, ¹RHEUM, VA, Palo Alto, CA, ²Internal medicine, Stanford University, stanford, CA, ³Internal Medicine, VA Palo Alto, Stanford, CA
Background/Purpose: Technological advances have facilitated the use of nontraditional forms of health care encounters, such as telemedicine. The aim of this study was to describe…
Abstract Number: 2498 • 2015 ACR/ARHP Annual Meeting
Barriers to Appointment Compliance and the Effect of Reminder Phone Calls on Lupus Clinic Show Rate in an Underserved Community
Anand Kumthekar¹ and Beverly Johnson², ¹Medicine, Albert Einstein College of Medicine/Jacobi Medical Center, Bronx, NY, ²Jacobi Medical Center, Albert Einstein College of Medicine, Bronx, NY
Background/Purpose: Appointment compliance is a nationwide problem with a higher prevalence in the underserved communities. For physicians it results in lost time, decreased efficiency, and…
Abstract Number: 2499 • 2015 ACR/ARHP Annual Meeting
No More No Shows: Improving the Appointment Reminder System at an Urban County Hospital Outpatient Rheumatology Clinic
Shire Beach¹, Sarah Goglin², Mary Margaretten^1,2, Laura Trupin¹ and Jinoos Yazdany², ¹University of California, San Francisco, San Francisco, CA, ²Rheumatology, University of California, San Francisco, San Francisco, CA
Background/Purpose: High appointment no-show rates lead to disrupted delivery of care and inefficient use of healthcare resources. Appointment reminder calls are cost-effective in lowering no-show…
Abstract Number: 2500 • 2015 ACR/ARHP Annual Meeting
Impact of Health Portal Enrollment and Electronic Appointment Reminders to Improve Appointment Attendance at an Academic Rheumatology Clinic
Arielle Mendel¹ and Shirley Chow², ¹Medicine, University of Toronto, Toronto, ON, Canada, ²Division of Rheumatology, University of Toronto, Toronto, ON, Canada
Background/Purpose: ‘No-shows’ (NS) to ambulatory care reduce the quality and efficiency of healthcare delivery. We sought to identify patient, provider, and system factors associated with…
Abstract Number: 2501 • 2015 ACR/ARHP Annual Meeting
Determining the Rate of Cardiovascular Risk Assessment in Patients with Rheumatoid Arthritis at Federally Qualified Outpatient Continuity Clinic – a Performance Improvement Project
Dewan Fahima¹ and Rafah Salloum², ¹Internal Medicine, Monmouth Medical Center, Long Branch, NJ, ²Rheumatology, Monmouth Medical Center, Long Branch, NJ
Background/Purpose: Studies have shown patients with rheumatoid arthritis (RA), a chronic inflammatory condition, have accelerated rate of coronary artery and cerebrovascular disease. Patients with RA,…
Abstract Number: 2502 • 2015 ACR/ARHP Annual Meeting
Implementation of New Pneumococcal Vaccination Recommendations in an Academic Rheumatology Clinic
Alison Bays¹, Renuka Nayak², David I. Daikh³, Jinoos Yazdany⁴ and Gabriela Schmajuk⁵, ¹Rheumatology, University of Washington, Seattle, WA, ²Rheumatology, UCSF, San Francisco, CA, ³Rheumatology, UCSF/VA Medical Center, San Francisco, CA, ⁴Rheumatology, UCSF, SF, CA, ⁵San Francisco VA Medical Center, University of California, San Francisco, San Francisco, CA
Background/Purpose: Invasive pneumococcal disease is approximately four times more common among patients with rheumatoid arthritis (RA) and systemic lupus erythematosus (SLE) compared to healthy counterparts.…
Abstract Number: 2503 • 2015 ACR/ARHP Annual Meeting
Improved Pneumococcal Vaccination in Rheumatoid Arthritis Patients in an Urban Academic Rheumatology Clinic
Swathi B. Reddy¹, Una E. Makris², Kara Prescott³ and E. Blair Solow², ¹Internal Medicine, Division of Rheumatic Diseases, UT Southwestern Medical Center, Dallas, TX, ²Rheumatology, UT Southwestern Medical Center, Dallas, TX, ³Internal Med - Rheumatology, Dallas VA Medical Center, Dallas, TX
Background/Purpose: Immunosuppressed patients are at higher risk for infections compared to the general population. Vaccines decrease morbidity and mortality, however vaccination status is not consistently…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].